Conference item icon

Conference item

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.

Publication status:
Published

Actions


Authors


Host title:
BLOOD
Volume:
106
Issue:
11
Pages:
960A-960A
Publication date:
2005-11-16
ISSN:
0006-4971
Pubs id:
pubs:346417
UUID:
uuid:90f43bae-cf2d-47ac-a193-8c53ded433b9
Local pid:
pubs:346417
Source identifiers:
346417
Deposit date:
2014-09-14

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP